DOCSLIB.ORG

Print Issue-4-2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Print Issue-4-2 issue-4-2 12/14/05 2:55 PM Page 1 issue-4-2 12/14/05 2:55 PM Page 2 issue-4-2 12/14/05 2:55 PM Page 3 issue-4-2 12/14/05 2:55 PM Page 4 Volume 4 Issue 2, January / February 2006 journal journal Cannabis Health Inside Truth motivated and submission driven, Cannabis Health prints your voices, opinions and Cannabis Health the facts, bringing the truth to light. Published 6 times a year, with a circulation of 40,000 throughout North America, we are 100% supported by our advertisers and subscribers.Article submissions are always welcome.Fully downloadable PDF versions of all issues are available at www.cannabishealth.com www.cannabishealth.com Ask an Expert Subscribe Today .................................................................................................5 MasterCard / Visa Accepted Editorials Call: 1 866 808 5566 New Farm Location .................................................................................................6 5695 Cooper Rd., Grand Forks, BC Canada Mailing Address: Box 1481 Marijuana and music Grand Forks BC Canada V0H 1H0 .................................................................................................7 Phone: 250 442 5166 Fax: 250 442 5167 Moving forward Toll Free: 1 866 808 5566 ...............................................................................................12 Email: [email protected] Towards a saner national drug policy ...............................................................................................15 Staff Keeping the door open: Dialogue on drug use EXECUTIVE EDITOR, BARB ST. JEAN [email protected] ...............................................................................................18 SENIOR EDITOR, LORRAINE LANGIS A look at New Zealand & cannabis law reform [email protected] PRODUCTION BRIAN McANDREW/BEYOND GRAPHIX ...............................................................................................21 [email protected] ADVERTISING MANAGER PAIGE GARNETT Cannabis health and context [email protected] DISTRIBUTION & SUBSCRIPTION MANAGER ...............................................................................................24 TERESA THOMSON [email protected] Harm reduction - the cannabis paradox ON-LINE STORE ...............................................................................................26 [email protected] WEBMASTER [email protected] What does it mean to feel better WEB SITE: Powered by Weblab ...............................................................................................27 GENERAL INQUIRIES [email protected] Naked defiance in rural BC Cannabis Health Journal is published six times a year. All contents copyright 2005 by Cannabis ...............................................................................................30 Health Journal. Cannabis Health Journal assumes no responsibility for any claims or representations Cannabis Health Contest contained in this magazine or in any submission or advertisement, nor do they encourage the illegal use ...............................................................................................31 of any of the products advertised within. No portion of this journal may be reproduced without the writ- Community Talking Stick ten consent of the publisher. ...............................................................................................33 OOPS! It has been brought to our attention there were some Silver Award “issue 7” errors on the advertisers listing page in our last issue. We 2003 Grand Forks apologize to any who may have been inadvertently omitted Chamber of Commerce or had a misspelling in their listing. Out of the Box Award 4 Cannabis Health journal issue-4-2 12/14/05 2:56 PM Page 5 DR. LESTER GRINSPOON, MD Question: other patients about this “new” psychopharmacological approach to I had been taking a drug called Zoloft for the past some clinical depressions. year. However, it made me sleepy all the time. For the Question: past three months I have been smoking a little Does cannabis have any effect on IBS (Irritable Bowl Syndrome) cannabis and realized it works for me. How can I tell I heard it may help? Thank you my psych. that I want to switch to marijuana? Do I even have the Answer: right to ask? Please advise. Thanks. The irritable bowel syndrome (IBS) is the most common gastroin- Answer: testinal disorder in clinical practice. The predominant symptoms are Cannabis first appeared in the Western medical literature as a intermittent constipation and/or watery diarrhea. The patients who suggested treatment for depression in the middle of the 19th century. report that marijuana is helpful in the symptomatic treatment of this Over the next hundred years medical papers supported and disputed disorder, I suspect, are those who suffer from the less frequent inter- the utility of marijuana in the treatment of depression. Today, mittent crampy lower abdominal pain. In any event, its usefulness in among the minority of depressed patients who do not respond to any IBS is not as compelling as it is for the much rarer recurrent inflam- of the standard antidepressants or who find the side effects unbear- matory disease of the digestive track, Crohn’s disease, the symptoms able, some have discovered that cannabis is more useful than any legal of which include cramps, nausea and vomiting, diarrhea, rectal bleed- drug, including Selective Serotonin Reuptake Inhibitors (SSRI’s) like ing, and loss of appetite and weight. Many people who suffer from Zoloft. It is important that you share this experience with your this bowel inflammatory disorder use marijuana with results which psychiatrist; you may find that he, like me, has already learned from are frequently dramatic. HILARY BLACK Question: Marijuana Information Resource Centre (MMIRC) website has a few I have a severe case of fibromyalgia. My doctor studies listed in the Pain section under the Therapeutic Uses. I (gp) will not sign the appropriate paper work to suggest you print and/or refer your physician to this section, and its’ allow me to buy marijuana for medicinal purposes. references. The same goes for the doctor at the pain clinic I go to If the physicians you are seeing have concerns about safety of every 3 weeks for nerve block injections. (42 injec- smoked cannabis, I recommend you present the emerging data that tions between my neck and lower back)Could you please inform me appears to suggest that smoked cannabis may be relatively safe in on what my options are, without disturbing my doctors who do not respect to cancer risk. One recent study that addresses this issue is believe marijuana is helping me deal with this horribly painful also available on the MMIRC website. disease? Steve. Answer: Many physicians are concerned about liability. The Canadian It is so unfortunate that you are having trouble finding a doctor Medical Protective Agency (CMPA), the organization that insures that is willing to authorize you to legally access cannabis in order to Canadian doctors, has developed a Release Form for Medical manage your symptoms. Many patients are experiencing this chal- Practitioners. This form is intended for the patient to take full lenge. It is essential to provide your doctors with the current clinical responsibility for any risks associated with the use of medical mari- data on the safety and efficacy of the medical use of marijuana. There juana. This form is accessible at the MMIRC website; you may want appears to be some compelling data on the effectiveness of cannabis to print and take it to your physician as well. Good Luck. and cannabinoids for the management of chronic pain. The Medical www.medicalmarijuanainformation.com THE EXPERTS DR. Lester Alan Young, DR. Mark A. Hilary Black DR. David W. Grinspoon, Barrister and Ware, BA, Ms. Black is a Pate, PhD, MD Solicitor, MBBS, MRCP, medicinal MSc. Professor of MSc, Dr. Grinspoon cannabis advocate Dr. Pate is a Law is a professor Dr. Ware is a & educator, having r esearcher emeritus of Professor pain specialist presented this specializing in psychiatry at Harvard Medical Young teaches law at Osgoode working at the Montreal General issue to a wide range of audiences. Cannabis and the cannabinoids, School and is one of the world’s Hall Law School and criminology Hospital. He is assistant professor She is also the founder and a past his academic background encom- leading authorities on the uses of at the University of Toronto. In of Anesthesia and of Family director of Canada’s first and passing both plant biology and marijuana for medicinal purpos- his twenty years of practicing Medicine at McGill University, largest organization of medicinal pharmaceutical chemistry. He es. Among many other criminal law, he has been and is involved in epidemiological cannabis advocacy, The British pursues particular interests in the achievements, he has authored 10 involved with some of Canada’s research and clinical trials of Columbia Compassion Club chemical ecology of Cannabis, books and more than 170 journal most signifcant and high-profle cannabis and cannabinoid Society. ophthalmic endocannabinoids articles and book chapters. medical marijuana cases. medications for chronic pain. and hempseed foods. Disclaimer: A notice of compliance has not been issued under the Food and Drug Regulations concerning the safety, effectiveness and risks of marijuana as a drug. Advice from these experts should not be construed as offering professional medical advice
Load more

Recommended publications
  • Cannabis in New Zealand Perceptions of Use, Users and Policy
    Cannabis in New Zealand perceptions of use, users and policy Geoff Noller A thesis submitted for the degree of Doctor of Philosophy at the University of Otago, Christchurch Aotearoa, New Zealand November 5, 2008 ABSTRACT Introduction Despite humanity’s lengthy relationship with psychoactive substances, their consumption in contemporary societies is perceived as highly problematic. Cannabis, the most commonly imbibed illicit psychotropic, has come to embody these concerns. Medical and scientific research informs notions of use and user, with these being further constructed in the public realm by law, the media and policy against a backdrop of health deficits and other harms including risk taking, criminality and deviance. With many studies drawing on clinical populations, e.g. high intensity users or those in treatment, a pathologized view of the user predominates. Where general population studies incorporate user data, these typically concentrate on the epidemiology of use: frequency, intensity, duration, and symptoms of abuse and dependence. This, however, tells us little about the meaning of use for users or why use continues despite universal official disapprobation. A lack of studies incorporating user perspectives thus ensures the limited focus of much present research and a policy accent on supply reduction at the expense of harm minimisation and safe use education. Those choosing to continue use are stigmatised as deviant or dependant. This has the effect of further bolstering enforcement, a strategy showing little evidence of efficacy. The present study sought a comparison between this dominant discourse on cannabis use and the perspectives of users, with a range of exploratory hypotheses being identified. Method Eighty cannabis-using respondents participated in open-ended face-to-face interviews, of which seventy-six successfully completed a follow-up questionnaire.
    [Show full text]
  • TY18:Layout 1 17/08/09 16:06 Pagina 1 TY18:Layout 1 17/08/09 16:06 Pagina 2 TY18:Layout 1 17/08/09 16:06 Pagina 3 TY18:Layout 1 17/08/09 16:06 Pagina 4
    TY18:Layout 1 17/08/09 16:06 Pagina 1 TY18:Layout 1 17/08/09 16:06 Pagina 2 TY18:Layout 1 17/08/09 16:06 Pagina 3 TY18:Layout 1 17/08/09 16:06 Pagina 4 Publisher/ Editor in Chief Marco Renda [email protected] Assistant to Editor Jef Tek [email protected] Copy Editor Aendrew Rininsland [email protected] Magazine design & layout Ivan Art [email protected] Director of Sales & Marketing Michelle Rainey [email protected] Technical Writer Ally a.k.a Pflover [email protected] Q&A Advisor Shantibaba [email protected] Text & photography Contributors Marco Renda, Ændrew Rininsland, Ivan Art, Michelle Rainey, Otto Snow, PFlover, Jef Tek, Shantibaba, Jerry B., Soma, Jay Generation, Harry Resin, Dr Dog, Chris Thompson, Jeremy Norrie, Keith Fagin, John (Shiva), Lara Lesack, Richard Owl Mirror, Suggarpaw, British Hempire, Jackie Sutton, Salvatore Messina HD., David B. Allen M.D., Hashmasta-Kut, Ale Keppel, Gregorio “Goyo” Fernandez Cover Pic `Mr Nice Critical Mass flower at 6 weeks` by Gregorio Fernandez “Goyo” for Mr. Nice Seedbank Submissions [email protected] Treating Yourself 250 The East Mall, P.O. Box 36531 Etobicoke, Ontario M9B 3Y8 Canada T: + 416 620 1951 F: +416 620 0698 Printed in Canada 4 - Treating Yourself, Issue 18- 2009 TY18:Layout 1 17/08/09 16:06 Pagina 5 Marco’s Editorial Well I have to say issue number 17 certainly caused a lot of controversy, especially surrounding the Dr Frankenbeanstien article. Both Sam The Skunkman and Ed Rosenthal contacted me regarding this. I offered them both the chance to rebut what was published, but they declined to do so.
    [Show full text]
  • Manifiesto Internacional OMS Cannabis Traducido 1:12
    Naciones Unidas E/CN.7/2020/NGO/7 Distr.: General Consejo Ecónomico y Social 25 November 2020 English only Comisión en drogas narcóticas Reanudada la sexagésimo tercera sesión Vienna, 2–4 diciembre 2020 Item 5 de la agenda provisional* Implementación de tratados de control de drogas internacionales Declaración presentada por la coalición europea por la justicia y políticas de drogas eficaces, una organización no gubernamental reconocida como entidad consultiva por el Consejo Social y Económico El Secretario-General ha recibido el siguiente manifiesto, el cual está siendo circulado de acuardo a los párrafos 36 y 37 de la resolución 1996/31 del Consejo Económico y Social __________________ * E/CN.7/2020/1/Add.1. ** Issued without formal editing. V.20-06992 (E) 261120 291120 *2006992* E/CN.7/2020/NGO/7 Manifiesto Apoya el acceso de pacientes a su medicina, ¡vota que sí! La cannabis ha sido una medicina convencional desde el amanecer de la civilización. En 1902 y 1929 las medicinas cannábicas fueron discutidas en la Conferencia Internacional por la Unificación de las Fórmulas Farmacopeicas para Drogas Potentes, la cual proporcionó pautas para armonizar las medicinas de cannabis y proveer a pacientes de drogas seguras y estandarizadas para sus tratamientos. Para este tiempo la cannabis ya era bastante aceptada en la práctica clínica y había sido reportada en las Farmacopeas de Austria, Bélgica, Francia, Hungaria, Italia, Japón, Holanda, Suiza, Reino Unido, Estados Unidos de América, así como en México y España. En 1958, las Naciones Unidas reportaron que la cannabis estaba también en las Farmacopeas de Argentina, Brazil, China, Egypt, Finland, India, Portugal, Romania, la URSS, y Venezuela.(2) Muchas preparacionas cannábicas están en textos ancestrales que componen la Farmacopea Ayurvédica (Charaka Samhita, Sushruta Samhita, Shargandhara Samhita) y en las Farmacopeas Mediterráneas de Umdat at-tabîb, Jami' al-mufradat, Hadîqat al-azhâr or Tuhfat al-ahbâb.
    [Show full text]
  • New Zealanders Experiences of Cannabis in Amsterdam While on Their Overseas Experience (OE)
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. i Flight of the Kiwi New Zealanders experiences of Cannabis in Amsterdam while on their Overseas Experience (OE) A thesis presented in partial fulfilment of the requirements for the Degree of Masters in Health Psychology At Massey University Manawatu New Zealand. Gabrielle Margaret Colley 2019 ii Abstract Cannabis consumption and travelling share a number of similarities, such as evoking pleasure or anxiety and, like in the title used to reflect this thesis, represent the experience of “flight” for the “Kiwi” (New Zealander). This thesis therefore explores both the experiences of cannabis consumption, a flight of the mind and travelling a flight of the body. The aim was to understand how New Zealanders experience cannabis in Amsterdam while they are undertaking a working holiday based in the United Kingdom (UK), known within Aotearoa New Zealand as an Overseas Experience (OE). Given Aotearoa New Zealand’s current political debates on cannabis control and the upcoming 2020 public referendum on legalising the substance, this thesis provides an opportunity to explore how New Zealanders experience cannabis within a liberal country that tolerates the sale of soft drugs in licensed premises, while growing up in a country that enforces cannabis prohibition. Statistics on cannabis use illustrate a steady rise in global consumption, however majority of countries still implement prohibition as a method of control, therefore choosing to study New Zealanders use of cannabis in a country without any legal ramification or stigmatisation for personal consumption allowed for greater transparency and in depth exploration.
    [Show full text]
  • Submission on the Misuse of Drugs Act Amendment Bill
    SUBMISSION ON MISUSE OF DRUGS ACT AMENDMENT BILL 2 010 This submission is from the National Organisation for the Reform of Marijuana Laws (NORML New Zealand Inc). We can be contacted at: Stephen McIntyre NORML New Zealand Inc. (09) 846 2680 PO Box 3307, [email protected] Auckland 1015 We would like to appear before the Committee to explain our views and answer any questions. Kiaora, 1. NORML New Zealand was founded in 1979 as a non-profit incorporated society that campaigns for an end to marijuana prohibition. We support the right of all adults to use, possess and grow their own cannabis. We recognise that some commercial market for marijuana will always exist, and we therefore promote ways to best to control that market. 1.1. Our aims are to: Reform New Zealand‟s marijuana laws Provide neutral, unbiased information about cannabis and its effects Engage in political action appropriate to our aims Inform people of their rights Give advice and support to victims of prohibition 1.2. We believe drug policy and associated laws should: Have realistic goals; Be regularly evaluated, be shown to be effective or be changed; take account of the different patterns and types of harms caused by specific drugs; Separate arguments about the consequences of drug use from arguments about morals; Be developed in the light of the costs of control as well as the benefits; Ensure that the harms caused by the control regimes themselves do not outweigh the harms prevented by them; Provide the greatest level of harm reduction for drug users, their families and their communities; Minimise the number of drug users who experience problems from their drug use; Be evidence based, as well as having the support of the community.
    [Show full text]
  • Download NORML's Submission to the New National Drug
    SUBMISSION ON “A NEW NATIONAL DRUG POLICY FOR NEW Z E A L A N D : DISCUSSION DOCUMENT ” This submission is from the National Organisation for the Reform of Marijuana Laws (NORML New Zealand Inc). We can be contacted at: Chris Fowlie NORML New Zealand Inc. (027) 297 6843 PO Box 3307, [email protected] Auckland 1140 Executive Summary 1. A complete rethink is needed of all drug control laws and policies. The lack of any willingness to look at first principles, and the missed opportunity to place the NDP in a world context, is especially sad given that NZ is now taking a world-leading initiative with "legal highs". 2. At a time when countries around the world are experimenting with alternative approaches to controlling drugs by implementing policies that reject the failed War on Drugs, this new National Drug Policy seems to be saying “let’s have more of the same”. 3. NORML endorses the consensus embodied in the Wellington Declaration, a consensus on a way forward for New Zealand's national drug policy. 4. Cannabis use should be a health issue, not a crime. There should be safe, legal access to medicinal cannabis. There should be an adults-only regulated and taxable market for cannabis and other low risk drugs. New Zealand’s world-leading Psychoactive Substances Act should be widened to include all low risk drugs, including cannabis. 5. New Zealand should investigate and learn from international developments including cannabis law reforms in Colorado, Washington, Uruguay, and the process to review the UN drug control treaties.
    [Show full text]
  • Cannabis a Practical Guide SECOND EDITION How to Regulate Cannabis a Practical Guide How to Regulate Cannabis a Practical Guide
    How to Regulate Cannabis A Practical Guide SECOND EDITION How to Regulate Cannabis A Practical Guide How to Regulate Cannabis A Practical Guide SECOND EDITION Updated October 2016 Transform Drug Policy Foundation Getting drugs under control Transform Drug Policy Foundation is an international, charitable think tank with staff in the UK and Mexico. We are working to get drugs under control by advocating for strict regulation of all aspects of the drug trade. We aim to equip policy makers and reform advocates with the tools they need to fundamentally change our current approach to drugs and create a healthier, safer world. Transform emerged in response to the increasingly apparent failings of current national and international drug policy. We draw attention to the fact that drug prohibition itself is the major cause of drug-related harm to individuals, communities and nations, and should be replaced by effective, just and humane government control and regulation. We provide evidence-based critiques of the war on drugs, new thinking on alternatives to the current enforcement-oriented regime of prohibition, and expertise on how to argue for reform. In addition to working with a broad range of media, civil society and professional groups globally, we advise national governments and multilateral organisations, and we hold ECOSOC special consultative status at the UN. www.tdpf.org.uk Our vision An end to the war on drugs and the establishment of an effective system of regulation that promotes health, peace and security, sustainable development
    [Show full text]
  • 20100510 Letter Woollard
    Submission 46 - Swensen & Crofts 1 The Chairman Dr Janet Woollard Education and Health Committee – Legislative Assembly Western Australian Parliament Re: Inquiry into the Adequacy and Appropriateness of Prevention and Treatment Services for Alcohol and Illicit Drug Problems in Western Australia This submission is to provide the Committee with information that has been generated through research that has been undertaken by Associate Professor Thomas Crofts, School of Law, Murdoch University and Greg Swensen a post graduate student at Murdoch University’s School of Law, related to some aspects of cannabis law reform. We are attaching copies of two short reports we have prepared over the past year that address some of the matters set out in your terms of reference, particularly with respect to your second term of reference: (2) To inquire into the impact on communities, and the social costs, of alcohol and illicit drug problems in Western Australia. The two attached papers are: • Cannabis law reforms: Recent developments • Cannabis smoking paraphernalia: A case for reform Whilst there is a more detailed consideration of cannabis law reform in WA and other jurisdictions in a monograph published in 2008 (Swensen G. The 2004 cannabis law reforms in Western Australia and the United Kingdom: A case of too much caution? Saarbrucken, Germany, VDM Verlag, 2008), these two papers provide additional information about recent developments that have occurred in Western Australia (WA). As noted in the papers, the marked variations in approach that have occurred in WA since late 1998 of how minor cannabis offenders may be best managed have been largely shaped by whether a conservative or progressive (ie social democratic) government has been in power.
    [Show full text]
  • GACETA N 7 MARZO 2019X.Pdf
    ARTÍCULO DEL MES, ARTÍCULOS LO QUE DEBES DIFUSIÓN DE EVENTOS DESCARGABLES SABER, IDENTIDAD ACADÉMICOS Y VIDEOGRAFÍA INSTITUCIONAL Día Mundial del Arte Prodecon/TFJA * El futuro de la regulación de la marihuana en México (Parte III) Cultura y arte Sitios de Interés Lo más relevante 8 Transparencia y acceso a la información Conferencia “Nuevas tasas del IVA en la región fronteriza norte y la Junta de Gobierno y Administración: Acuerdos E/JGA/7/2019 y eliminación de la compensación universal” E/JGA/8/2019 Programa interdisciplinario Política de igualdad laboral y no discriminación del Tribunal Federal de Justicia Administrativa Derechos humanos, derechos de la víctimas, Crónica Legislativa constitucionalismo transformador Diario ocial (Diciembre 2018 - Febrero 2019) i Prodecon/TFJA Cultura y arte Sitios de Interés 8 Transparencia y acceso a la información Junta de Gobierno y Administración: Acuerdos E/JGA/7/2019 y E/JGA/8/2019 Política de igualdad laboral y no discriminación del Tribunal Federal de Justicia Administrativa Crónica Legislativa Diario ocial (Diciembre 2018 - Febrero 2019) ii Día Mundial del Arte Convocatoria a Concurso “Expresiones Artísticas” http://www.tfjfa.gob.mx/media/media/index_files/miscelanea/2019/cartel-dia-arte.jpg 1 hacer eficaz el derecho a la salud de la El Futuro de la Regulación de población en general. la Marihuana en México Des- Inconformes con esa decisión, los quejosos criminalización, Despenaliza- interpusieron recurso de revisión, en el que ción, Legalización o Permane- alegaron fundamentalmente que —contrario a lo establecido por el Juez de Distrito— “la nor- ce Penalizada mativa impugnada impone modelos y estánda- res de vida ajenos a los particulares, pues sólo Xochitl GARMENDIA CEDILLO se respeta la identidad de cada sujeto si se le CAPÍTULO CUARTO permite actuar en consecuencia a sus propios Sentencia de la Suprema Corte de Justicia de la rasgos, cosmovisiones, concepciones de la vida Nación sobre el consumo de la marihuana para buena y elementos que a su juicio lo definen y efectos lúdicos singularizan”.
    [Show full text]
  • Regímenes Legales Del Cannabis Alrededor Del Mundo Por Rebeca Calzada
    @espolea /Espolea www.espolea.org REGÍMENES LEGALES DEL CANNABIS ALREDEDOR DEL MUNDO POR REBECA CALZADA El día de hoy, la mayoría de los países condenan y prohíben la producción, distribución, compra-venta, posesión y uso de la planta del cannabis con fines recreativos y médicos. Sin embargo, los regímenes legales al respecto han variado a lo largo de los últimos años en distintas zonas del planeta. Diversos países han comenzado a legislar de manera alternativa al prohibicionismo. Este Documento de Trabajo (DDT) mapea los distintos estados legales del cannabis alrededor del mundo. 1. LOS DISTINTOS REGÍMENES LEGALES A pesar de la creación del marco internacional punitivo en torno a la política de drogas, la realidad es que las normas en torno al cannabis varían mucho de país en país, e incluso difieren dentro de estos mismos. Algunos países han preferido actuar bajo enfoques de salud pública, de derechos humanos y de reducción de riesgos y daños. Otros han preferido modelos más estrictos, utilizando el derecho penal para sancionar la posesión y el consumo. En este DDT, dividimos los regímenes legales del cannabis en dos grandes rubros:1, 2 LEGALIZACIÓN Es el proceso por el cual el estatus de una actividad pasa de estar prohibida a estar permitida. En el debate sobre política de drogas, el término es frecuentemente utilizado para referirse a la producción, distribución, venta y posesión legal de sustancias previamente controladas.3 Sin embargo, es importante subrayar que el término legalización describe un proceso y no un modelo de política pública. De ahí que la legalización de una o todas las drogas actualmente controladas pueda derivar en la instrumentación de políticas públicas distintas: la regulación legal o el libre mercado.
    [Show full text]
  • 4 Case Studies of Cannabis Law Reform
    4 Case Studies of Cannabis Law Reform 4.1 Introduction This chapter examines some of the key processes that have occurred to reform the law concerning minor cannabis offences in WA, the UK and NZ since the 1970s. These three jurisdictions have been selected as they have similar political and parliamentary systems, share a common legal heritage323 and in relation to drug laws, have a very similar trajectory in the evolution of drugs laws and policies that have been adopted.324 Our interest in examining the UK and WA is that reform through the parliamentary process resulted in legislation to establish a legal framework in early 2004 for police to have alternatives to prosecute minor cannabis offenders, whereas in NZ legislative reform has so far not occurred in spite of similar debates about policy reform. Although NZ may have progressed a short distance along the road to cannabis law reform, this has been confined to administrative measures for limited formal cautioning of minor cannabis offenders. The interest in NZ is how reform has been stymied largely due to political constraints because of the leverage by minority parties who used their position to enable Helen Clarke to form a minority Labour government, but included restrictions on cannabis law reform in the enabling agreement. The NZ situation also demonstrates the value and importance of non-parliamentary avenues to create support for reform when the parliamentary process is unable to implement legislative reform.325 A number of threads evident in these three jurisdictions will be examined. One thread concerns the strength and advantages a government having control of the parliamentary process to reform cannabis laws.
    [Show full text]
  • Synthetic Cannabinoid Use in New Zealand: Assessing the Harms
    Synthetic Cannabinoid Use in New Zealand: Assessing the harms A report to The STAR Trust Prepared by Geoff Noller, PhD Substance Use and Policy Analysis 2014 Acknowledgements Personnel from a number of organisations contributed to the preparation of this report, including staff from the Police, Alcohol Drug Helpline and CARM. Bruce Atmore, Principal Advisor, New Regulators Establishment Unit, and Ministry of Health, and colleagues were similarly helpful in providing public health surveillance data and related material. Prof. Paul Glue (Department of Psychological Medicine, University of Otago School of Medicine) offered valuable feedback on an earlier draft. Citation: Noller, G. (2014). Synthetic cannabinoid use in New Zealand: Assessing the harms. Report #01. The STAR Trust. Auckland: New Zealand. CONTENTS EXECUTIVE SUMMARY......................................................................................................1 1 INTRODUCTION.................................................................................................................3 PART 1. SYNTHETIC CANNABINOIDS.........................................................................3 1.1 BACKGROUND...............................................................................................................3 1.2 INTERNATIONAL LITERATURE ......................................................................................4 1.2.1 Prevalence.............................................................................................................5 1.2.2 Harms reported
    [Show full text]